Soleimani M, Jalilvand A
Sci Rep. 2025; 15(1):7450.
PMID: 40032988
PMC: 11876366.
DOI: 10.1038/s41598-025-91246-y.
Melo V, do Brasil P
Glob Epidemiol. 2025; 9():100181.
PMID: 39850445
PMC: 11754157.
DOI: 10.1016/j.gloepi.2024.100181.
Hanage W, Schaffner W
Infect Dis Ther. 2024; 14(Suppl 1):5-37.
PMID: 39739200
PMC: 11724833.
DOI: 10.1007/s40121-024-01080-4.
Shivappa P, Parmar S, Menezes G, Sekar P, Ahmad H, Hossain A
J Pharm Bioallied Sci. 2024; 16(3):93-103.
PMID: 39691541
PMC: 11648584.
DOI: 10.4103/jpbs.jpbs_514_24.
Kvach M, Nikitin O, Kost A, Banyra O
Cent European J Urol. 2024; 77(2):298-303.
PMID: 39345316
PMC: 11428368.
DOI: 10.5173/ceju.2024.263.
Evolution of serious and life-threatening COVID-19 pneumonia as the SARS-CoV-2 pandemic progressed: an observational study of mortality to 60 days after admission to a 15-hospital US health system.
Murthy S, Gordon S, Lowry A, Blackstone E
BMJ Open. 2024; 14(7):e075028.
PMID: 38977360
PMC: 11256047.
DOI: 10.1136/bmjopen-2023-075028.
Community antibiotic prescribing in patients with COVID-19 across three pandemic waves: a population-based study in Scotland, UK.
Ciaccio L, Donnan P, Parcell B, Marwick C
BMJ Open. 2024; 14(4):e081930.
PMID: 38643000
PMC: 11033633.
DOI: 10.1136/bmjopen-2023-081930.
Genomic Surveillance of SARS-CoV-2 Sequence Variants at Universities in Southwest Idaho.
Chase J, Bond L, Vail D, Sengthep M, Rodriguez A, Christianson J
COVID. 2024; 4(1):23-37.
PMID: 38549916
PMC: 10977930.
DOI: 10.3390/covid4010003.
Analysis of characteristics of and risk factors for otological symptoms after COVID-19 infection.
Wang Q, Gu H, Ren J, Zhao Y, Meng Z
PLoS One. 2024; 19(2):e0297100.
PMID: 38300969
PMC: 10833509.
DOI: 10.1371/journal.pone.0297100.
The impact of SARS-CoV-2 on healthcare workers of a large University Hospital in the Veneto Region: risk of infection and clinical presentation in relation to different pandemic phases and some relevant determinants.
Liviero F, Volpin A, Furlan P, Battistella M, Broggio A, Fabris L
Front Public Health. 2023; 11:1250911.
PMID: 38098828
PMC: 10720910.
DOI: 10.3389/fpubh.2023.1250911.
Number of initial symptoms of SARS-CoV-2 infection is associated with the risk of otological symptoms: a retrospective study.
Wang Q, Gu H, Tao Y, Zhao Y, Meng Z
BMC Infect Dis. 2023; 23(1):862.
PMID: 38062350
PMC: 10704705.
DOI: 10.1186/s12879-023-08866-w.
Frequency and Risk Factors for Persistent and Concomitant Symptoms after Hospital Discharge for Coronavirus Disease 2019 in the Pre-omicron Period: An Exploratory Longitudinal Study.
Kobuchi T, Onishi H, Yamamura O, Sakamaki I, Iwasaki H, Hayashi H
JMA J. 2023; 6(4):437-447.
PMID: 37941692
PMC: 10628324.
DOI: 10.31662/jmaj.2023-0054.
Clinical symptom profile of hospitalized COVID-19 Brazilian patients according to SARS-CoV-2 variants.
Hojo-Souza N, Freitas V, Guidoni D, Hojo de Souza F
Epidemiol Health. 2023; 45:e2023079.
PMID: 37654165
PMC: 10867512.
DOI: 10.4178/epih.e2023079.
Robust cross-cohort gut microbiome associations with COVID-19 severity.
Li J, Ghosh T, McCann R, Mallon P, Hill C, Draper L
Gut Microbes. 2023; 15(1):2242615.
PMID: 37550964
PMC: 10411309.
DOI: 10.1080/19490976.2023.2242615.
Efficacy and Safety of Add-On Plant-Based Drugs for COVID-19 Patients: A Review of the Randomized Control Trials.
Diantini A, Febriyanti R, Levita J
Infect Drug Resist. 2023; 16:3879-3891.
PMID: 37361940
PMC: 10289101.
DOI: 10.2147/IDR.S417727.
Mycolactone: A Broad Spectrum Multitarget Antiviral Active in the Picomolar Range for COVID-19 Prevention and Cure.
Asiedu S, Gupta Y, Nicolaescu V, Gula H, Caulfield T, Durvasula R
Int J Mol Sci. 2023; 24(8).
PMID: 37108313
PMC: 10139166.
DOI: 10.3390/ijms24087151.
